standard-title Test plugin

Test plugin

Titolo Fase Natura dello studio Tipo studio Stato Sede patologia Dettaglio

A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 REGIMEN DURATION (3 VERSUS 6 MONTHS) AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER

III

NoProfit

Interventistico - Farmacologico

fine arruolamento continua followup

Gastrointestinale

A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 REGIMEN DURATION (3 VERSUS 6 MONTHS) AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER

III

NoProfit

Interventistico - Farmacologico

fine arruolamento continua followup

Gastrointestinale

A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 REGIMEN DURATION (3 VERSUS 6 MONTHS) AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER

III

NoProfit

Interventistico - Farmacologico

fine arruolamento continua followup

Gastrointestinale

A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 REGIMEN DURATION (3 VERSUS 6 MONTHS) AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER

III

NoProfit

Interventistico - Farmacologico

fine arruolamento continua followup

Gastrointestinale

A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 REGIMEN DURATION (3 VERSUS 6 MONTHS) AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER

III

NoProfit

Interventistico - Farmacologico

fine arruolamento continua followup

Gastrointestinale

Loading…